Samsara Bio Capital, LLC Nkarta, Inc. Call Options Transaction History
Samsara Bio Capital, LLC
- $317 Million
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NKTX
# of Institutions
121Shares Held
52.8MCall Options Held
145KPut Options Held
114K-
Boxer Capital, LLC San Diego, CA5.61MShares$29.5 Million3.15% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.19MShares$27.3 Million1.16% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.8MShares$20 Million0.08% of portfolio
-
Nea Management Company, LLC Timonium, MD3.57MShares$18.8 Million2.71% of portfolio
-
Sr One Capital Management, LP3.33MShares$17.5 Million12.13% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $256M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...